Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 01 08 2019
accepted: 04 12 2019
pubmed: 14 12 2019
medline: 2 4 2021
entrez: 14 12 2019
Statut: ppublish

Résumé

Quantifying rotavirus shedding among vaccinated individuals will aid understanding of vaccine indirect effects. Serial stool samples were collected from 196 children who presented with rotavirus gastroenteritis to health facilities in Blantyre, Malawi, and were tested for rotavirus using a VP6 semi-quantitative, real-time polymerase chain reaction. The median duration of fecal shedding was 28 days (95% CI, 19-28). The median copy numbers for peak shedding were 1.99 × 107 (interquartile range, 3.39 × 106 to 6.37 × 107). The fecal viral load was positively associated with disease severity and negatively associated with serum anti-rotavirus immunoglobin A. High and persistent rotavirus shedding among vaccinated children with breakthrough disease may contribute to ongoing transmission in this setting.

Identifiants

pubmed: 31834930
pii: 5676855
doi: 10.1093/infdis/jiz612
pmc: PMC7661767
doi:

Substances chimiques

NSP3 protein, Rotavirus 0
Rotavirus Vaccines 0
Viral Nonstructural Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2035-2040

Subventions

Organisme : Wellcome Trust
ID : 201945/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI112970
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125842
Pays : United States
Organisme : Wellcome Trust
ID : 102466/Z/13/A
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102464/Z/13/A
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 091909/Z/10/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101113/Z/13/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

J Med Virol. 2013 Sep;85(9):1661-8
pubmed: 23775335
Lancet. 1998 Jun 20;351(9119):1844-8
pubmed: 9652668
Clin Infect Dis. 2017 Oct 1;65(7):1144-1151
pubmed: 28575304
Clin Infect Dis. 2016 May 1;62 Suppl 2:S91-5
pubmed: 27059361
Clin Infect Dis. 2016 May 1;62 Suppl 2:S213-9
pubmed: 27059359
J Med Virol. 2004 May;73(1):118-22
pubmed: 15042658
Lancet. 1999 Jul 24;354(9175):287-90
pubmed: 10440305
Vaccine. 2014 Aug 11;32 Suppl 1:A55-61
pubmed: 25091682
Curr Opin Virol. 2012 Aug;2(4):419-25
pubmed: 22677178
Clin Infect Dis. 2012 Jan 15;54(2):185-92
pubmed: 22109945
Bull World Health Organ. 2007 Jun;85(6):441-8
pubmed: 17639241
J Med Virol. 2008 Aug;80(8):1489-96
pubmed: 18551614
J Clin Microbiol. 2015 Jun;53(6):1951-4
pubmed: 25854480
J Pediatr Gastroenterol Nutr. 1985 Feb;4(1):60-6
pubmed: 2984402

Auteurs

Aisleen Bennett (A)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.

Louisa Pollock (L)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.

Khuzwayo C Jere (KC)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.

Virginia E Pitzer (VE)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.

Benjamin Lopman (B)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Naor Bar-Zeev (N)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
International Vaccine Access Center, Bloomberg School of Public Health, John Hopkins University, Baltimore, Maryland, USA.

Miren Iturriza-Gomara (M)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.
National Institute for Health Research (NIHR) Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool, United Kingdom.

Nigel A Cunliffe (NA)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.
Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH